BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 22198502)

  • 1. P38 MAPK is involved in enhanced NMDA receptor-dependent excitotoxicity in YAC transgenic mouse model of Huntington disease.
    Fan J; Gladding CM; Wang L; Zhang LY; Kaufman AM; Milnerwood AJ; Raymond LA
    Neurobiol Dis; 2012 Mar; 45(3):999-1009. PubMed ID: 22198502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of postsynaptic density protein-95 with NMDA receptors influences excitotoxicity in the yeast artificial chromosome mouse model of Huntington's disease.
    Fan J; Cowan CM; Zhang LY; Hayden MR; Raymond LA
    J Neurosci; 2009 Sep; 29(35):10928-38. PubMed ID: 19726651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyglutamine-modulated striatal calpain activity in YAC transgenic huntington disease mouse model: impact on NMDA receptor function and toxicity.
    Cowan CM; Fan MM; Fan J; Shehadeh J; Zhang LY; Graham RK; Hayden MR; Raymond LA
    J Neurosci; 2008 Nov; 28(48):12725-35. PubMed ID: 19036965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in STriatal-Enriched protein tyrosine Phosphatase expression, activation, and downstream signaling in early and late stages of the YAC128 Huntington's disease mouse model.
    Gladding CM; Fan J; Zhang LY; Wang L; Xu J; Li EH; Lombroso PJ; Raymond LA
    J Neurochem; 2014 Jul; 130(1):145-59. PubMed ID: 24588402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitigation of augmented extrasynaptic NMDAR signaling and apoptosis in cortico-striatal co-cultures from Huntington's disease mice.
    Milnerwood AJ; Kaufman AM; Sepers MD; Gladding CM; Zhang L; Wang L; Fan J; Coquinco A; Qiao JY; Lee H; Wang YT; Cynader M; Raymond LA
    Neurobiol Dis; 2012 Oct; 48(1):40-51. PubMed ID: 22668780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.
    Shehadeh J; Fernandes HB; Zeron Mullins MM; Graham RK; Leavitt BR; Hayden MR; Raymond LA
    Neurobiol Dis; 2006 Feb; 21(2):392-403. PubMed ID: 16165367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calpain and STriatal-Enriched protein tyrosine phosphatase (STEP) activation contribute to extrasynaptic NMDA receptor localization in a Huntington's disease mouse model.
    Gladding CM; Sepers MD; Xu J; Zhang LY; Milnerwood AJ; Lombroso PJ; Raymond LA
    Hum Mol Genet; 2012 Sep; 21(17):3739-52. PubMed ID: 22523092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model.
    Kolodziejczyk K; Raymond LA
    Neurobiol Dis; 2016 Feb; 86():62-74. PubMed ID: 26621114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic blockade of extrasynaptic NMDA receptors ameliorates synaptic dysfunction and pro-death signaling in Huntington disease transgenic mice.
    Dau A; Gladding CM; Sepers MD; Raymond LA
    Neurobiol Dis; 2014 Feb; 62():533-42. PubMed ID: 24269729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease.
    Fan MM; Fernandes HB; Zhang LY; Hayden MR; Raymond LA
    J Neurosci; 2007 Apr; 27(14):3768-79. PubMed ID: 17409241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A.
    Metzler M; Gan L; Mazarei G; Graham RK; Liu L; Bissada N; Lu G; Leavitt BR; Hayden MR
    J Neurosci; 2010 Oct; 30(43):14318-29. PubMed ID: 20980587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
    Zeron MM; Hansson O; Chen N; Wellington CL; Leavitt BR; Brundin P; Hayden MR; Raymond LA
    Neuron; 2002 Mar; 33(6):849-60. PubMed ID: 11906693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional control of postsynaptic density-95 (PSD-95) clustering by Huntingtin.
    Parsons MP; Kang R; Buren C; Dau A; Southwell AL; Doty CN; Sanders SS; Hayden MR; Raymond LA
    J Biol Chem; 2014 Feb; 289(6):3518-28. PubMed ID: 24347167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial sensitivity and altered calcium handling underlie enhanced NMDA-induced apoptosis in YAC128 model of Huntington's disease.
    Fernandes HB; Baimbridge KG; Church J; Hayden MR; Raymond LA
    J Neurosci; 2007 Dec; 27(50):13614-23. PubMed ID: 18077673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibiting pro-death NMDA receptor signaling dependent on the NR2 PDZ ligand may not affect synaptic function or synaptic NMDA receptor signaling to gene expression.
    Martel MA; Soriano FX; Baxter P; Rickman C; Duncan R; Wyllie DJ; Hardingham GE
    Channels (Austin); 2009; 3(1):12-5. PubMed ID: 19221512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced striatal NR2B-containing N-methyl-D-aspartate receptor-mediated synaptic currents in a mouse model of Huntington disease.
    Li L; Murphy TH; Hayden MR; Raymond LA
    J Neurophysiol; 2004 Nov; 92(5):2738-46. PubMed ID: 15240759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-methyl-D-aspartate receptor subunit- and neuronal-type dependence of excitotoxic signaling through post-synaptic density 95.
    Fan J; Vasuta OC; Zhang LY; Wang L; George A; Raymond LA
    J Neurochem; 2010 Nov; 115(4):1045-56. PubMed ID: 20831617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing roles of synaptic and extrasynaptic NMDA receptor signaling in cocultured striatal and cortical neurons.
    Kaufman AM; Milnerwood AJ; Sepers MD; Coquinco A; She K; Wang L; Lee H; Craig AM; Cynader M; Raymond LA
    J Neurosci; 2012 Mar; 32(12):3992-4003. PubMed ID: 22442066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease.
    Zeron MM; Fernandes HB; Krebs C; Shehadeh J; Wellington CL; Leavitt BR; Baimbridge KG; Hayden MR; Raymond LA
    Mol Cell Neurosci; 2004 Mar; 25(3):469-79. PubMed ID: 15033175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.